LYPRO BIOSCIENCES INC

ALAMEDA, CA · Still private

Claim this profile

Follows are private to you and power your alerts

Updated

Headquarters
ALAMEDA, CA
Latest Form D
$178K, Sep 2010
Total capital
$2.7M
Federal grants
$2.5M
6 awards · 2005–2009
Private capital raised
$178K
1 Form D · last Sep 2010
194 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

200520062007200820092010FEDERAL ↑EQUITY ↓Cumulative $2.7M$421K$746K$726K$109K1st Form D$178K
200520062007200820092010FEDERAL ↑EQUITY ↓Cumulative $2.7M$746K$726K1st Form D$178K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$178K
  • Federal grantHealth and Human S · Phase I · Nanobiotechnology for the Treatment of Mantle Cell Lymphoma$109K
  • Federal grantHealth and Human S · Phase I · Inhalable amphotericin B nanodisk therapy for pulmonary aspergillosis$100K
  • Federal grantHealth and Human S · Phase II · Inhalable amphotericin B nanodisk therapy for aspergillosis in HIV-infected patie$406K
  • Federal grantHealth and Human S · Phase II · NanoDisk-Amphotericin B therapy for aspergillosis$726K
  • Federal grantHealth and Human S · Phase II · NanoDisk-Amphotericin B therapy for aspergillosis$746K
  • Federal grantHealth and Human S · Phase II · Inhalable amphotericin B nanodisk therapy for aspergillosis in HIV-infected patie$421K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

62months

from LYPRO BIOSCIENCES INC’s first federal award to its first private round.

First federal award · Jul 2005
Health and Human S · $421K
First Form D · Sep 2010
$178K · 1st Form D
Awards before first raise
6 awards

An association in public records, not a cause or a prediction.

Founders and team

From SEC Form D filings
  • Michelle Stecklein CallExecutive Officer, DirectorNamed in SEC Form D filings
  • Robert O. RyanDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .